Ticker
VIVSCompany Name
VIVOSIM LABS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Shareholders Equity | Market Capitalization | Price to Book |
---|---|---|---|
6/30/2025 | $ 9.54M | $ 4.56M | 0.48 |
3/31/2025 | $ 10.49M | $ 4.77M | 0.45 |
12/31/2024 | $ 364K | $ 6.58M | 18.08 |
9/30/2024 | $ 3.68M | $ 6.17M | 1.68 |
6/30/2024 | $ 6.66M | $ 8.25M | 1.24 |
3/31/2024 | $ 3.6M | $ 14.13M | 3.92 |
12/31/2023 | $ 6.18M | $ 10.04M | 1.62 |
9/30/2023 | $ 8.46M | $ 12.9M | 1.53 |
6/30/2023 | $ 11.78M | $ 13.86M | 1.18 |
3/31/2023 | $ 15.33M | $ 15.08M | 0.98 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap / Equity
(=) P/B
P/B for VIVOSIM LABS INC is calculated as follows: Market Cap [ $ 69.74M ] / Equity [ $ 19.99M ]
(=) P/B [ 3.49 ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.36K |
---|---|
min | 0 |
max | 8.04 |
average | 2.3 |
median | 1.63 |
std | 1.81 |